NICOLE VOGUS: Open Payments
NPI 1568098432 · BETHEL PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 27 payments from 8 companies in 2025. Trend: 2023 $63 · 2024 $329 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| Recor Medical Inc | 7 | $408 |
| Novo Nordisk Inc | 2 | $152 |
| Amgen Inc. | 7 | $139 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Paradise Ultrasound Renal Denervation System, REPATHA, Ozempic, LEQVIO, CAMZYOS, LifeVest, Wegovy, JARDIANCE.
Industry payments across PA — which companies pay providers there.
